EA039776B1 - Новые белки, полученные из альфа-1-микроглобулина, и их применение - Google Patents

Новые белки, полученные из альфа-1-микроглобулина, и их применение Download PDF

Info

Publication number
EA039776B1
EA039776B1 EA201892085A EA201892085A EA039776B1 EA 039776 B1 EA039776 B1 EA 039776B1 EA 201892085 A EA201892085 A EA 201892085A EA 201892085 A EA201892085 A EA 201892085A EA 039776 B1 EA039776 B1 EA 039776B1
Authority
EA
Eurasian Patent Office
Prior art keywords
absent
asp
seq
met
lys
Prior art date
Application number
EA201892085A
Other languages
English (en)
Russian (ru)
Other versions
EA201892085A1 (ru
Inventor
Лена Вестер Розенлёф
Аннели Эдстрем Хегервалль
Бо Окерстрем
Original Assignee
Гард Терапьютикс Интернэшнл Айби
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Гард Терапьютикс Интернэшнл Айби filed Critical Гард Терапьютикс Интернэшнл Айби
Publication of EA201892085A1 publication Critical patent/EA201892085A1/ru
Publication of EA039776B1 publication Critical patent/EA039776B1/ru

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K14/00Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4717Plasma globulins, lactoglobulin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00Drugs for disorders of the urinary system
    • A61P13/12Drugs for disorders of the urinary system of the kidneys
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Urology & Nephrology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
EA201892085A 2016-03-18 2017-03-17 Новые белки, полученные из альфа-1-микроглобулина, и их применение EA039776B1 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DKPA201670158 2016-03-18
PCT/EP2017/056436 WO2017158181A1 (en) 2016-03-18 2017-03-17 Novel alpha-1-microglobulin derived proteins and their use

Publications (2)

Publication Number Publication Date
EA201892085A1 EA201892085A1 (ru) 2019-02-28
EA039776B1 true EA039776B1 (ru) 2022-03-11

Family

ID=56080208

Family Applications (1)

Application Number Title Priority Date Filing Date
EA201892085A EA039776B1 (ru) 2016-03-18 2017-03-17 Новые белки, полученные из альфа-1-микроглобулина, и их применение

Country Status (15)

Country Link
US (1) US10981963B2 (enExample)
EP (1) EP3430032B1 (enExample)
JP (1) JP6976579B2 (enExample)
KR (1) KR102437662B1 (enExample)
CN (1) CN108779157B (enExample)
AU (1) AU2017235608B2 (enExample)
BR (1) BR112018068522A2 (enExample)
CA (1) CA3017836A1 (enExample)
EA (1) EA039776B1 (enExample)
ES (1) ES2896734T3 (enExample)
MX (1) MX2018011193A (enExample)
NZ (1) NZ746677A (enExample)
SG (1) SG11201807352XA (enExample)
WO (1) WO2017158181A1 (enExample)
ZA (1) ZA201805797B (enExample)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN111511386A (zh) * 2017-11-03 2020-08-07 卫士医疗国际公司 α-1-微球蛋白用于保护骨髓细胞的用途
WO2024165674A1 (en) 2023-02-08 2024-08-15 Guard Therapeutics International AB Alpha-1-microglobulin derived peptide fragments and uses thereof
US12227343B2 (en) * 2023-03-17 2025-02-18 Blue Buffalo Enterpises, Inc. Retail ready opening feature for e-commerce carton

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010006809A2 (en) * 2008-07-18 2010-01-21 Akerstroem Bo Medical use of the radical scavenger and antioxidant alpha-1-microglobulin
WO2014037390A1 (en) * 2012-09-05 2014-03-13 A1M Pharma Ab Alpha-1-microglobulin for use in the treatment of mitochondria-related diseases

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2013113851A1 (en) * 2012-01-31 2013-08-08 Technische Universitaet Muenchen Muteins of a1m lipocalin and method of production therefor
WO2014047490A1 (en) * 2012-09-21 2014-03-27 Beintoo, S.P.A. Interactive experience fully contained within an expandalble embedded unit
US10226570B2 (en) * 2017-03-10 2019-03-12 Seton Healthcare Family Apparatus and method for temporarily securing a movable accessory device relative to a movable patient

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010006809A2 (en) * 2008-07-18 2010-01-21 Akerstroem Bo Medical use of the radical scavenger and antioxidant alpha-1-microglobulin
WO2014037390A1 (en) * 2012-09-05 2014-03-13 A1M Pharma Ab Alpha-1-microglobulin for use in the treatment of mitochondria-related diseases

Also Published As

Publication number Publication date
SG11201807352XA (en) 2018-09-27
ES2896734T3 (es) 2022-02-25
WO2017158181A1 (en) 2017-09-21
JP2019519466A (ja) 2019-07-11
NZ746677A (en) 2023-02-24
EP3430032A1 (en) 2019-01-23
CN108779157B (zh) 2022-12-30
US10981963B2 (en) 2021-04-20
BR112018068522A2 (pt) 2019-01-22
US20190161524A1 (en) 2019-05-30
EA201892085A1 (ru) 2019-02-28
KR102437662B1 (ko) 2022-08-29
EP3430032B1 (en) 2021-09-01
CN108779157A (zh) 2018-11-09
ZA201805797B (en) 2022-03-30
CA3017836A1 (en) 2017-09-21
AU2017235608A1 (en) 2018-10-18
MX2018011193A (es) 2019-03-28
JP6976579B2 (ja) 2021-12-08
KR20180127411A (ko) 2018-11-28
AU2017235608B2 (en) 2020-10-22

Similar Documents

Publication Publication Date Title
EA039776B1 (ru) Новые белки, полученные из альфа-1-микроглобулина, и их применение
EP2964774A1 (en) Ptd-smad7 therapeutics
CA2801579C (en) Methods for treatment of nephrotic syndrome and related conditions
KR102221041B1 (ko) 신증후군 및 관련 병태의 치료 방법
US11866468B2 (en) Methods for treatment of nephrotic syndrome and related conditions
TW201643199A (zh) 用於放射性核種治療中保護腎臟之α-1-微球蛋白
US20190054142A1 (en) Alpha-1-microglobulin for use in the protection of kidneys in connection with use of contrast media
HK1252916B (en) Use of an angiopoietin-like 4 (angptl4) polypeptide in the manufacture of a medicament for the treatment of proteinuria.